Introducing a zebrafish line without importing disease

A new zebrafish line may be scientifically valuable while carrying a health status that cannot be judged from appearance. Subclinical infections can travel with adults, embryos, shipping water or associated equipment. If introduction is poorly controlled, a shared recirculating system can expose several racks, compromise fish welfare and add an unrecognised biological variable to experiments. The practical question is therefore not simply how many days a shipment should be isolated. Facilities need to define the hazards they intend to exclude, the barriers that can contain them and the evidence required before release.

Start the assessment before shipment

FELASA–AALAS recommendations describe four steps for introducing a new fish colony: consider the relevant trade and national requirements; assess risk from the source and developmental stage; establish effective quarantine barriers; and triage, screen and, where justified, treat imported fish.

The receiving facility should request a current health-monitoring report and a useful history for the source epidemiological unit. The record should identify which agents were tested, by which methods, on what samples and dates, and which agents were not tested. It should also describe the water system, husbandry, recent imports, morbidity or mortality events and action taken after a detection. A negative label without a defined population, sampling period and method is not enough to support a risk decision.

That evidence must be compared with the receiving facility’s exclusion list and research portfolio. Immunocompromised lines and studies of immunity, microbiota, behaviour or inflammation may be especially vulnerable to opportunistic or subclinical infection. Yet an unlimited exclusion list is not automatically feasible or scientifically necessary. The veterinarian, facility manager, researcher and diagnostic laboratory should agree on an acceptable risk level before animals move.

Choose embryos or adults for a reason

Receiving embryos rather than adults can reduce selected risks and limit the number of animals transported. Zebrafish husbandry recommendations support breeding imported adults under quarantine and, where appropriate, introducing progeny derived from surface-disinfected eggs. This strategy does not make embryos sterile. It may not control organisms that are internal, associated with reproductive tissues or insufficiently susceptible to the selected treatment.

Surface disinfection must therefore remain one barrier within a broader programme. Product identity, active concentration, preparation water, embryo age, contact time, rinsing and line-specific tolerance all need documentation. A procedure that preserves embryo viability does not by itself demonstrate microbiological efficacy against the organisms on the exclusion list.

When adults are necessary, shipping water should not enter either the quarantine system or established holding systems. Temperature acclimation and transfer should minimise stress without mixing equipment from sending and receiving sites. Genetic identity, fish number, sex and developmental stage should be verified separately from health status: confirming genotype does not confirm pathogen freedom, and a satisfactory health report does not confirm the line’s identity.

Quarantine must function as a biological barrier

A tank labelled “quarantine” is not sufficient. The unit should prevent water return, avoidable splashes and transfer of contaminated equipment to established colonies. A separate room is preferable. Where that is impossible, stand-alone life support, clear spatial organisation and compensating procedures need to create a barrier that can be audited. Nets, breeding tanks, siphons, measuring equipment, containers and consumables should be dedicated and visibly distinguishable.

Staff movement should proceed from units with the best-known status towards higher-risk units. If that order cannot be maintained, local procedures should define changes of personal protective equipment, hand and footwear hygiene and any necessary interval. Wastewater, carcasses, waste, live feed and equipment awaiting cleaning also need routes that do not cross clean materials. The plan should specify who may enter, who records events and who can authorise an exception.

An international survey by Mocho and von Krogh collected responses from 145 facilities in 23 countries. About one quarter reported no health-monitoring system. Most used some form of quarantine for imported fish, but only a small fraction described routines providing reliable biological barriers, and fewer than one in five screened fish for pathogens while they were in quarantine. These were self-reported practices rather than an efficacy trial, but the findings expose the difference between having an isolation space and operating a defensible biosecurity programme.

Combine observation with diagnostic evidence

Daily surveillance should record mortality, appetite, reproductive performance, body condition, swimming, distribution within the tank and external signs. The absence of visible disease does not exclude subclinical infection. Conversely, a clinical event should trigger investigation rather than immediate attribution to a particular agent.

The diagnostic plan should combine targeted and broad methods according to risk. PCR can address a defined organism. Histopathology may detect lesions or unexpected agents, while microscopy and culture add value in selected scenarios. FELASA–AALAS examples use sick or surplus fish as well as environmental material such as tank or sump sludge. No sample type or method covers every pathogen, so selection must consider infection stage and the epidemiological unit the sample actually represents.

A positive molecular result does not necessarily prove that viable organisms are present. A negative result does not establish absence when sampling coverage, timing or analytical sensitivity are inadequate. Pooling can improve efficiency but may dilute a rare target. Interpretation rules, controls, the response to an indeterminate result and the fate of the line after detection should all be agreed before samples are submitted.

Release against criteria, not a calendar alone

The evidence does not support a single quarantine duration for every zebrafish line. The appropriate period depends on the organisms of concern, their biology, the received stage, breeding timetable, available tests and reliability of containment. Reaching a date cannot compensate for an incomplete health history or an uninterpretable result.

Release criteria may include satisfactory observation, breeding from clinically normal parents, a validated egg-disinfection process, results consistent with the testing plan and final review by named decision-makers. Progeny should move in clean containers without quarantine water, equipment or adults. Traceability should link every transferred group to its parents, treatments, diagnostic results and release decision.

Detection does not always reduce the decision to acceptance or culling. Depending on the organism, research objectives and available capacity, a facility may extend isolation, confirm the finding, rederive a line through breeding and egg disinfection, treat when veterinary and scientific justification exists, preserve genetic material or reject the import. The response should protect established colonies without applying a disproportionate default.

A checklist for welfare and reproducibility

Before each transfer, the receiving team should be able to answer six questions: which epidemiological unit supplied the line and what is known about it; which agents matter most; why embryos or adults are being received; which barriers genuinely separate workflows; which samples and methods will support release; and who owns the final decision? If one answer is missing, postponing shipment is usually less disruptive than investigating contamination across the main facility.

Vetofish can support research facilities with import risk assessment, health-report review, quarantine workflow design, sampling plans and joint interpretation of diagnostic findings. The goal is a proportionate, traceable introduction tailored to the line and research programme—not a fixed waiting period or isolated test presented as a health guarantee.